ES8305414A1 - Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces. - Google Patents

Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.

Info

Publication number
ES8305414A1
ES8305414A1 ES508984A ES508984A ES8305414A1 ES 8305414 A1 ES8305414 A1 ES 8305414A1 ES 508984 A ES508984 A ES 508984A ES 508984 A ES508984 A ES 508984A ES 8305414 A1 ES8305414 A1 ES 8305414A1
Authority
ES
Spain
Prior art keywords
preparation
medicines
component
antibiotic compound
peptide antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES508984A
Other languages
English (en)
Other versions
ES508984A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES508984A0 publication Critical patent/ES508984A0/es
Publication of ES8305414A1 publication Critical patent/ES8305414A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE UN COMPUESTO ANTIBIOTICO DE LA CEPA STREPTOMYCES, DE FORMULA (I), MEDIANTE METODO MICROBIOLOGICO. CONSISTE EN CULTIVAR, EN CONDICIONES AEROBICAS SUBMERSAS, STREPTOMYCES SPEC. WS 116 (DSM 1692), EN UN MEDIO NUTRIENTE QUE CONTIENE CARBONO ASIMILABLE, NITROGENO Y SALES MINERALES, ESPECIALMENTE SALES DE HIERRO, A UNA TEMPERATURA ENTRE 15 C Y 35 C; Y SEPARACION DEL COMPUESTO FORMADO DEL LIQUIDO DE FERMENTACION MEDIANTE UNA RESINA DE ABSORCION Y DESORCION CON MEZCLAS DE AGUA Y DISOLVENTES ORGANICOS.
ES508984A 1981-01-23 1982-01-22 Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces. Expired ES8305414A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813102136 DE3102136A1 (de) 1981-01-23 1981-01-23 Neue verbindung bay i 3265 komponente a, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ES508984A0 ES508984A0 (es) 1983-04-01
ES8305414A1 true ES8305414A1 (es) 1983-04-01

Family

ID=6123194

Family Applications (1)

Application Number Title Priority Date Filing Date
ES508984A Expired ES8305414A1 (es) 1981-01-23 1982-01-22 Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.

Country Status (6)

Country Link
US (1) US4416870A (es)
EP (1) EP0057812B1 (es)
JP (1) JPS57142999A (es)
AT (1) ATE8133T1 (es)
DE (2) DE3102136A1 (es)
ES (1) ES8305414A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3126389A1 (de) * 1981-07-03 1983-02-10 Bayer Ag, 5090 Leverkusen Neue antibiotisch wirksame verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3236389A1 (de) * 1982-10-01 1984-04-05 Bayer Ag, 5090 Leverkusen Neue nucleosidverbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3341571A1 (de) * 1983-11-17 1985-05-30 Bayer Ag, 5090 Leverkusen Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung
IE902574A1 (en) * 1989-07-17 1991-02-27 Univ Birmingham Antiviral pyrimidine nucleosides
CN113149990B (zh) * 2020-01-23 2024-04-02 嘉圣生物医药(嘉兴)有限公司 铁载体-二氢叶酸还原酶抑制剂偶联物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158608A (en) * 1975-08-20 1979-06-19 Bayer Aktiengesellschaft Fungicidally active antibiotic from Streptomyces tendae Ettlinger
DE3020722A1 (de) * 1980-05-31 1981-12-10 Bayer Ag, 5090 Leverkusen Verfahren zur anreicherung von nikkomycin-gemischen

Also Published As

Publication number Publication date
US4416870A (en) 1983-11-22
EP0057812A3 (en) 1982-09-01
EP0057812A2 (de) 1982-08-18
ES508984A0 (es) 1983-04-01
DE3102136A1 (de) 1982-08-19
JPS57142999A (en) 1982-09-03
DE3260276D1 (en) 1984-08-02
ATE8133T1 (de) 1984-07-15
EP0057812B1 (de) 1984-06-27

Similar Documents

Publication Publication Date Title
TW229208B (es)
TW221811B (es)
ES8500932A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
AP9300561A0 (en) Antibiotic compounds.
ES8301274A1 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
MY104937A (en) Cephalosporin derivatives and processes for their preparation
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
ES8305414A1 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
ES479636A1 (es) Procedimiento para la obtencion de un antibiotico de efecto sinergistico.
IL99898A0 (en) 7-acyl-3-substituted carbamoyloxy cephem compounds,their preparation and antibacterial compositions containing them
DE3268339D1 (en) Novel semisynthetic macrolidic antibiotics, microbiological processes for their preparation and related microorganism, novel intermediate compounds for their preparation and related pharmaceutical compositions containing them
GB1482651A (en) Pharmaceutical products
ES8308303A1 (es) Procedimiento para obtencion de derivados antibioticos de la cepa streptomyces spec. ws 116
MY101079A (en) Pharmaceutical formulation for the treatment of bacterial infections.
ES8206544A1 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas
ES8507554A1 (es) Procedimiento para la obtencion de carboximetilesteres
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
GB1396840A (en) Sulphanilamides and a process for the manufacture thereof
JO1531B1 (en) New near-compounds
JO1711B1 (en) Therapeutic agents
GB1262761A (en) 06alpha,17-ALKYLIDENEDIOXY-18-METHYL-19-NORPROGESTERONES
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009